Related Experiment Video

Updated: Jun 17, 2026

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
09:26

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells

Published on: February 20, 2015

Role of platelet-derived microparticles in angiogenesis and tumor progression

David Varon1, Elai Shai

  • 1Coagulation Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. dvaron@hadassah.org.il

Discovery Medicine
|December 31, 2009
PubMed

Insights

Platelet-derived microparticles (PMP) extend beyond hemostasis, influencing angiogenesis and cancer metastasis. High PMP levels correlate with aggressive tumors, suggesting potential as biomarkers or therapeutic targets.

Area of Science:

  • Vascular Biology
  • Cellular Biology
  • Oncology

Background:

  • Platelets are crucial for hemostasis and vascular biology, including angiogenesis and tissue regeneration.
  • Microparticles (MP) are vesicles shed from activated or apoptotic cells; platelet-derived microparticles (PMP) are the most abundant circulating MP.
  • PMP possess functions beyond coagulation, impacting various physiological and pathological processes.

Purpose of the Study:

  • To review the non-hemostatic roles of platelet-derived microparticles (PMP).
  • To explore the involvement of PMP in vascular biology, inflammation, and cancer metastasis.
  • To discuss the potential of PMP as diagnostic biomarkers and therapeutic targets.

Main Methods:

  • Literature review summarizing existing research on PMP functions.
  • Analysis of studies investigating PMP interactions with cells and their impact on signaling pathways.
  • Examination of data correlating PMP levels with disease states, particularly cancer.

Main Results:

  • PMP transfer functional receptors, modulate cell adhesion molecule expression, and stimulate cytokine release.
  • PMP influence intracellular signaling, vascular reactivity, and angiogenesis.
  • Elevated PMP levels are associated with aggressive tumors and poor clinical outcomes, potentially promoting cancer cell proliferation and adhesion.

Conclusions:

  • PMP play multifaceted roles in vascular biology and disease pathogenesis, including cancer.
  • PMP may serve as valuable biomarkers for disease status and potential targets for anti-platelet therapies.
  • Targeted local application of PMP could offer novel therapeutic strategies for angiogenesis-related conditions.

More Related Videos

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures08:02

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures

Published on: July 27, 2022

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...